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Abstract
Lipopolysaccharide (LPS) activates neutrophils and monocytes, inducing a wide array of biological activities. LPS rough (R) and 
smooth (S) forms signal through Toll-like receptor 4 (TLR4), but differ in their requirement for CD14. Since the R-form LPS can 
interact with TLR4 independent of CD14 and the differential expression of CD14 on neutrophils and monocytes, we used the 
S-form LPS from Salmonella abortus equi and the R-form LPS from Salmonella minnesota mutants to evaluate LPS-induced 
activation of human neutrophils and monocytes in whole blood from healthy volunteers. Expression of cell surface receptors 
and reactive oxygen species (ROS) and nitric oxide (NO) generation were measured by flow cytometry in whole blood mono-
cytes and neutrophils. The oxidative burst was quantified by measuring the oxidation of 2’,7’-dichlorofluorescein diacetate and 
the NO production was quantified by measuring the oxidation of 4-amino-5-methylamino-2’,7’-difluorofluorescein diacetate. A 
small increase of TLR4 expression by monocytes was observed after 6 h of LPS stimulation. Monocyte CD14 modulation by 
LPS was biphasic, with an initial 30% increase followed by a 40% decrease in expression after 6 h of incubation. Expression 
of CD11b was rapidly up-regulated, doubling after 5 min on monocytes, while down-regulation of CXCR2 was observed on 
neutrophils, reaching a 50% reduction after 6 h. LPS induced low production of ROS and NO. This study shows a complex 
LPS-induced cell surface receptor modulation on human monocytes and neutrophils, with up- and down-regulation depending 
on the receptor. R- and S-form LPS activate human neutrophils similarly, despite the low CD14 expression, if the stimulation 
occurs in whole blood.
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Introduction
Interaction between the innate immune system and mi-
crobial constituents is the basis of pathogen recognition and 
induced cellular activation (1). Lipopolysaccharide (LPS), 
present in Gram-negative bacteria, is a primary target for the 
recognition of bacteria, and elicits many of their pathogenic 
effects as well as a protective immune response (2). The 
interaction between LPS and cells of the innate immune 
system, such as neutrophils and monocytes, triggers an in-
flammatory response, driven to control the infection process, 
but that also may trigger the pathophysiological response 
leading to severe sepsis and septic shock (3).
LPS-induced cell activation is mediated by the Toll-like 
receptor 4 (TLR4) (4), and is dependent on LPS-binding 
protein and the CD14 receptor [as membrane-bound 
(mCD14) or soluble (sCD14) protein] (5). Signal transduction 
by TLRs requires association with myeloid differentiation 
protein 2 (6) and occurs by two pathways, one depending 
on the myeloid differentiation primary response gene (88) 
(MyD88) and the other MyD88-independent. The former 
induces activation of mitogen-activated protein kinases 
and translocation of transcriptional factor κB (NF-κB). The 
MyD88-independent signal activates interferon regulatory 
factor 3 and also NF-κB, although on a late basis (7). Both 
signaling pathways are involved in oxidative burst and 
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induction of nitric oxide (NO) (8,9).
LPS-induced cell activation in whole blood has the 
advantage of preserving the microenvironment of LPS 
and cell interaction as it occurs in vivo; however, studies 
of the effects of LPS on different cell populations in whole 
blood are scarce. Flow cytometry permits the study of the 
effects of LPS in whole blood at the cellular level (10,11). 
Macrophages are considered to be the primary targets of 
LPS, and neutrophils have also been reported as highly 
LPS-responsive cells. In the present study, we evaluated 
the modulation of cell surface receptors, oxidative burst 
and NO production by neutrophils and monocytes in whole 
blood of human volunteers.
Recently, it has been shown that the rough (R)-form 
LPS can interact with TLR4 without CD14 (12,13). Re-form 
LPS (lipid A + two 3-deoxy-D-manno-2-octurosonic acid 
residues), but not the smooth (S)-form LPS, can induce 
tumor necrosis factor-alpha (TNF-α) responses also in the 
absence of CD14 (12). R-form LPS was a potent activator of 
mast cells (that lack CD14), while S-form LPS was practically 
devoid of stimulatory activity (13). Since human neutrophils 
either lack or express low amounts of mCD14, it became 
important to study if LPS-induced neutrophil activation is 
different when stimulated by S- or R-form LPS. For this 
reason, we used both LPS types in the present study. 
Material and Methods
Reagents
S-form LPS from Salmonella abortus equi and R-form 
LPS from Salmonella minnesota mutants (R595 (Re)) were 
extracted from parent bacteria and purified as previously 
described (14). 
The following monoclonal antibodies were used: 
CD66b-fluorescein isothiocyanate (FITC), clone G1OF5; 
CD14-peridinin-chlorophyll-protein (PerCP), clone M8P9; 
CD11b-allophycocyanin (APC), clone D12; CD11c-APC, 
clone S-HCL-3; CD15-APC, clone HI98, and CXCR2-APC, 
clone 6C6 were obtained from BD Biosciences (USA). 
TLR2-phycoerythrin (PE), clone TL2.1 and TLR4-PE, clone 
HTA125 were obtained from eBioscience (USA). p50-PE, 
clone sc-8414 and p65-PE, clone sc-8008 were obtained 
from Santa Cruz Biotechnology (USA).
Healthy volunteers
The study was approved by the Universidade Federal 
de São Paulo Ethics Committee (process No. 1304/05) and 
written informed consent was obtained from all volunteers. 
Blood samples from 21 volunteers (mean age: 28 ± 7 years, 
38% males) were used. 
Cell surface receptor expression in whole blood in 
response to R- or S-form LPS
Expression of cell surface receptors on monocytes and 
neutrophils was determined in whole blood as previously 
described (15). Cells were stained with 6 µL CD14-PerCP 
and 5 µL CD66b-FITC in order to identify monocytes and 
neutrophils, respectively. For kinetics, the cells were also 
stained with 20 µL TLR4-PE and 2 µL CD11b-APC (tube 
1), 20 µL TLR2-PE and 2 µL CD11c-APC (tube 2), or 2 
µL CXCR2-APC (tube 3). A dose-response assay was 
performed with CD11b-APC.
Event acquisition and analyses were performed us-
ing the CellQuest software (BD Biosciences) and an 
FACSCalibur 4-color flow cytometer (BD Biosciences). 
Monocyte analyses were carried out using forward and 
side scatter parameters combined with CD14-positive- and 
CD66b-negative-stained cells, and neutrophil analyses 
were performed using forward and side scatter parameters 
combined with CD66b-positive- and CD14-negative-stained 
cells. Surface receptor expression was measured as the 
geometric mean fluorescence intensity (GMFI). 
Analysis of oxidative burst in whole blood after 
stimulation with R- or S-form LPS
The oxidative burst was quantified by measuring the 
oxidation of 2’,7’-dichlorofluorescein diacetate (DCFH-DA, 
Sigma, USA) in whole blood as previously described (16). 
Neutrophils in whole blood were characterized by side 
scatter and forward scatter parameters and negativity for 
CD14 and monocytes was characterized by side scatter and 
forward scatter parameters and positive staining for CD14. 
Reactive oxygen species (ROS) generation is reported in 
histograms and expressed as the GMFI.
Analysis of NO production in whole blood after 
stimulation with R- or S-form LPS
NO production was quantified by measuring the oxida-
tion of 4-amino-5-methylamino-2’,7’-difluorofluorescein 
diacetate (Invitrogen, USA) in whole blood by the method 
of Zelnickova et al. (17), modified. Cells were stained with 
5 µL CD14-PE and 5 µL CD15-FITC for monocyte and 
neutrophil identification, respectively. NO generation is 
reported in histograms and expressed as the GMFI.
Statistical analysis 
Data are reported as means ± SEM and were compared 
by analysis of variance (ANOVA) and the post hoc Tukey 
honestly significant difference (HSD) test. The software 
used was SPSS 13.0 for Windows (USA).
Results
LPS-induced modulation of the expression of cell 
surface receptors in whole blood
Induction of CD11b in monocytes and neutrophils by 
LPS: dose-response. Whole blood samples were stimulated 
for 30 min with different amounts of R- or S-form LPS (1-
100 ng/mL) and the expression of CD11b on monocytes 
and neutrophils was determined by fluorescence-activating 
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cell sorting (FACS). The 100-ng LPS/mL dose was chosen 
and used for stimulation throughout the study (data not 
shown). 
Kinetics of LPS-induced modulation of surface recep-
tor expression on monocytes. The modulation of receptor 
expression on monocytes was monitored between 5 min 
and 24 h after the addition of LPS to whole blood cultures. 
Although no changes in TLR4 expression were observed 
by 180 min, a significant up-regulation by both R- and S-
form LPS was seen after 6 h of culture (P = 0.039; Figure 
1A), with a return to normal after 24 h (data not shown). 
No changes in TLR2 expression were detectable during 
the observation period (data not shown). CD14 expression 
was increased after 15-30 min (P = 0.034 and P = 0.050) 
of stimulation, returned to normal levels at 180 min and 
decreased after 6 h (P < 0.001; Figure 1B), a condition 
that persisted up to the end of the 24-h observation period. 
Increased CD11b expression was observed as early as 5 
min after the addition of LPS and was highest after 6 h of 
incubation (Figure 1C), with similar effects for both LPS 
forms. R- and S-form LPS-induced CD11c expression on 
monocytes reached no statistical significance compared 
to control (Figure 1D). 
Kinetics of LPS-induced modulation of surface recep-
tor expression on neutrophils. The modulation of receptor 
expression on neutrophils was monitored between 5 min 
and 24 h after the addition of LPS to whole blood cultures. 
The expression of TLR2 and TLR4 was not modulated by 
R- or S-form LPS (data not shown). CD14 surface expres-
sion on neutrophils was only marginal compared to that 
on monocytes. Thus, human neutrophils have little or no 
mCD14 on their surface, and its expression was not induced 
by either R- or S-form LPS (data not shown). 
Both LPS forms induced a decrease of CXCR2 expres-
sion on neutrophils, already present after 15 min and ob-
served throughout the 6 h of the experiment (Figure 2A).
CD66b expression was significantly up-regulated by 
both R- and S-form LPS (P = 0.028 and P = 0.006, after 3 
Figure 1. Expression of cell surface receptors on monocytes in whole blood after incubation with medium (control) or with 100 ng/mL 
rough (R)- or smooth (S)-form lipopolysaccharide (LPS). A, C, and D, Monocytes were gated based on forward and side scatter pa-
rameters and positive staining for CD14. The cell surface receptor expression was measured as geometric mean fluorescence intensity 
(GMFI) and is reported as means ± SEM for each time. B, Monocytes were gated based on forward and side scatter parameters and 
CD14 expression is represented as the ratio of CD14 expression between stimulated cells and controls. A, Results of TLR4 expres-
sion obtained from 4 individuals. B, Results of CD14 expression obtained from 10 healthy volunteers. C, Results of CD11b expression 
obtained from 5 individuals. D, Results of CD11c expression obtained from 4 individuals. *P ≤ 0.05 for group comparison (ANOVA), ◊P 
≤ 0.05 for S-form LPS versus control (Tukey post hoc test) and #P ≤ 0.05 for R-form LPS versus control (Tukey post hoc test).
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h and 6 h of stimulation, respectively, Figure 2B). S-form 
LPS seems to have an earlier effect in inducing CD66b 
expression (Figure 2B). CD66b expression on stimulated 
cells remained elevated up to 24 h of incubation (data not 
shown).
CD11b expression on neutrophils, similar to that on 
monocytes, was rapidly up-regulated by 15 min of stimula-
tion, increased gradually with time (Figure 2C), persisting at 
an elevated level up to 24 h of stimulation (data not shown). 
When the Tukey test was performed, both LPS forms 
showed activity. In contrast, the expression of CD11c on 
neutrophils was low and did not significantly increase after 
blood was cultured with R- or S-form LPS (Figure 2D).
LPS-induced production of ROS and NO by 
monocytes and neutrophils in whole blood
A dose-dependent production of ROS was generated 
in monocytes and neutrophils within 30 min when whole 
blood samples were stimulated with LPS. No significant 
differences in ROS generation activity were observed be-
tween the two LPS forms (Figure 3A and B). A significant 
induction of NO was observed in monocytes (Figure 4A), 
but not in neutrophils (Figure 4B) after 30 min of stimulation 
with 100 ng/mL R- and S-form LPS (P = 0.019).
Discussion
We investigated the modulation of a wide range of cell 
surface receptors on human monocytes and neutrophils 
involved in bacterial recognition, chemotaxis, and cell-to-
cell interactions, in whole blood of human volunteers using 
the S- and R-forms of LPS.
In agreement with numerous other studies we show 
that not only monocytes, but also neutrophils, express the 
signaling receptor for LPS, TLR4 (11). However, in contrast 
to some reports (18,19), we observed no down-regulation of 
Figure 2. Expression of cell surface receptors on neutrophils in whole blood after incubation with medium (control) or with 100 ng/
mL rough (R)- or smooth (S)-form lipopolysaccharide (LPS). A, C, and D, Neutrophils were gated based on forward and side scatter 
parameters and positive staining for CD66b. The cell surface receptor expression was measured as geometric mean fluorescence 
intensity (GMFI) and is reported as means ± SEM for each time. B, Neutrophils were gated based on forward and side scatter param-
eters and CD66b expression was measured as GMFI and is reported as means ± SEM for each time. A, Results of CXCR2 expression 
obtained from 6 individuals. B, Results of CD66b expression obtained from 9 individuals. C, Results of CD11b expression obtained 
from 4 individuals. D, Results of CD11c expression obtained from 4 individuals. *P ≤ 0.05 for group comparison (ANOVA), ◊P ≤ 0.05 for 
S-form LPS versus control (Tukey post hoc test) and #P ≤ 0.05 for R-form LPS versus control (Tukey post hoc test).
LPS-induced monocyte and neutrophil activation 857
www.bjournal.com.br Braz J Med Biol Res 43(9) 2010
TLR4 on monocytes during the initial period of stimulation 
(up to 3 h after LPS), but rather a weak, transient increase 
at 6 h after LPS. In addition, we found no changes in 
TLR4 expression in LPS-stimulated neutrophils. We also 
investigated the impact of LPS activation on the expres-
sion of TLR2 on both cell types. No major changes in TLR2 
levels on the surface of monocytes and neutrophils were 
observed when whole blood samples were stimulated with 
LPS up to 24 h. 
While the expression of the LPS-binding co-receptor 
CD14 on monocytes has been well documented, the pres-
ence of CD14 on neutrophils is not so clear. Some investi-
gators claim that CD14 is expressed in polymorphonuclear 
neutrophils, although to a lesser extent in monocytes (18), 
and a positive modulation of CD14 expression on neutrophils 
by LPS has been reported (20). FACS analysis of the pres-
ent data showed that the levels of CD14 on unstimulated 
neutrophils were marginal or absent and, in agreement 
with Wright et al. (21), not affected by LPS stimulation. This 
absence of significant amounts of CD14 is also indirectly 
supported by results of an earlier study (22), in which only 
R-form LPS preparations elicited oxidative responses in 
isolated neutrophils, while the S-form LPS was virtually 
inactive. Since it is known today that only the R-form LPS 
can activate TLR4-positive cells independent of CD14 (12), 
retrospectively the inability of the S-form LPS to activate neu-
trophils under serum-free conditions (22) can be explained 
by the absence of CD14 on human neutrophils.
As previously shown (23), LPS modulated the expres-
sion of mCD14 on monocytes. The rapid increase of mCD14 
expression (15 and 30 min after the addition of LPS) was 
followed by a strong decrease of expression between 6 and 
24 h later compared to control. This kinetics is not fully con-
sistent with finding reported by others. Some investigators 
(24) did not detect a change in response of peripheral blood 
mononuclear cells (PBMC) after the addition of the S-form 
LPS after 120 min, others (25) observed an initial decrease 
followed by a sharp increase after 24 h of PBMC incubation, 
while still others (23) described a positive modulation of 
CD14 on whole blood monocytes during 4 h of incubation. 
The finding of LPS-induced down-regulation of CD14 raises 
the question of whether this effect might be involved in the 
down-regulation of the pro-inflammatory response during 
re-exposure of target cells to LPS. Here, however, the 
concomitant unsuppressed or even enhanced production 
of anti-inflammatory proteins (26) had to be explained. 
We show here that both LPS forms substantially up-
regulated the expression of CD11b on monocytes and 
neutrophils. CD11b up-regulation persisted during the 6 
h of LPS stimulation on monocytes and neutrophils, in 
contrast to Haugen et al. (27), who found both up- and 
down-regulation of its expression. These discrepancies 
may be due to different experimental conditions. CD11 
molecules (a, b, c, d)/CD18 β2 integrins are important for 
cell adhesion to the endothelium (28) and CD11b/CD18 has 
Figure 3. Production of reactive oxygen species (ROS) by mono-
cytes (A) and neutrophils (B) in response to different concentra-
tions of rough (R)- or smooth (S)-form lipopolysaccharide (LPS, 0, 
100, 250, 500, and 1000 ng/mL) applied for 30 min. ROS produc-
tion is reported as geometric mean fluorescence intensity (GMFI) 
and is reported as means ± SEM for each concentration. Results 
obtained from 3 individuals.
Figure 4. Nitric oxide (NO) production by monocytes and neutro-
phils after incubation with medium (control) or 100 ng/mL rough 
(R)- or smooth (S)-form lipopolysaccharide (LPS) for 30 min. 
Monocytes (A) were gated based on forward and side scatter pa-
rameters and positive CD14 staining, and neutrophils (B) based 
on forward and side scatter parameters and positive staining for 
CD15. NO production was measured as geometric mean fluores-
cence intensity (GMFI) of benzotriazolic derivate and is reported 
as means ± SEM for each stimulus. Results obtained from 7 indi-
viduals. *P < 0.05 compared to control (ANOVA and Tukey post 
hoc test).
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